Dr Roebuck’s, a Sydney, Australia-based skin care brand, closed a financing round with Unilever Ventures.
The amount of the deal was not disclosed.
The company intends to use the funds to scale its direct retail operations globally, accelerate its market growth, enhance the infrastructure and strategically invest in product innovation and R&D.
Launched in 2016 by sisters Zoe and Kim Roebuck, Dr Roebuck’s is a skin care brand powered by clean, effective, multi-benefit ingredients, many of which are native to Australia. Products are cruelty-free, suitable for all skin types, and free of parabens, sulfates, gluten, fillers, synthetic fragrances, harmful chemicals and dyes.
The brand recently expanded to 20 countries globally and is today sold in over 2,000 doors and online via strategic partnerships with Sephora, Shopper’s Drug Mart, Cult Beauty and SpaceNK. The products are available for purchase at Sephora stores nationwide and Sephora.com, as well as DrRoebucks.com.
FinSMEs
26/04/2019